These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
24. Mechanisms of protein degradation: what do the rat studies tell us. Bailey JL; Mitch WE J Nephrol; 2000; 13(2):89-95. PubMed ID: 10858969 [TBL] [Abstract][Full Text] [Related]
25. [What is the contribution of Stewart's concept in acid-base disorders analysis?]. Quintard H; Hubert S; Ichai C Ann Fr Anesth Reanim; 2007 May; 26(5):423-33. PubMed ID: 17462852 [TBL] [Abstract][Full Text] [Related]
26. Control of muscle protein kinetics by acid-base balance. Caso G; Garlick PJ Curr Opin Clin Nutr Metab Care; 2005 Jan; 8(1):73-6. PubMed ID: 15586003 [TBL] [Abstract][Full Text] [Related]
27. Metabolic acidosis and bone disease. Eiam-ong S; Kurtzman NA Miner Electrolyte Metab; 1994; 20(1-2):72-80. PubMed ID: 8202056 [TBL] [Abstract][Full Text] [Related]
28. The role of parathyroid hormone and vitamin D in acid excretion and extrarenal buffer mobilization. Stim JA; Bernardo AA; Arruda JA Miner Electrolyte Metab; 1994; 20(1-2):60-71. PubMed ID: 8202054 [TBL] [Abstract][Full Text] [Related]
29. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease. Kraut JA; Madias NE Adv Chronic Kidney Dis; 2017 Sep; 24(5):289-297. PubMed ID: 29031355 [TBL] [Abstract][Full Text] [Related]
30. [Metabolic and immunological disorder in CKD]. Yasuda Y; Yuzawa Y; Matsuo S Nihon Rinsho; 2008 Sep; 66(9):1678-86. PubMed ID: 18788394 [No Abstract] [Full Text] [Related]
31. Differential diagnosis of metabolic acidosis. Casaletto JJ Emerg Med Clin North Am; 2005 Aug; 23(3):771-87, ix. PubMed ID: 15982545 [TBL] [Abstract][Full Text] [Related]
32. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients]. Inaguma D; Tatematsu M Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827 [TBL] [Abstract][Full Text] [Related]
33. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Kraut JA; Kurtz I Am J Kidney Dis; 2005 Jun; 45(6):978-93. PubMed ID: 15957126 [TBL] [Abstract][Full Text] [Related]
34. Derangement of acid-base balance in uremia and under hemodialysis. Messa P; Mioni G; Maio GD; Ferrando C; Lamperi D; Famularo A; Paoletti E; Cannella G J Nephrol; 2001; 14 Suppl 4():S12-21. PubMed ID: 11798141 [TBL] [Abstract][Full Text] [Related]
36. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Raggi P; Kleerekoper M Clin J Am Soc Nephrol; 2008 May; 3(3):836-43. PubMed ID: 18322050 [TBL] [Abstract][Full Text] [Related]
37. [Pathogenesis and diagnosis of systemic acidosis in animals with conclusions for effective forms of therapy]. Hartmann H; Berchtold J Tierarztl Prax Ausg G Grosstiere Nutztiere; 1997 Nov; 25(6):611-24. PubMed ID: 9451767 [TBL] [Abstract][Full Text] [Related]
38. [Metabolic acidosis in patients with chronic kidney diseases: why and when to treat it?]. Sofia A; Cappelli V; Valli A; Garibotto G G Ital Nefrol; 2005; 22(1):28-36. PubMed ID: 15786375 [TBL] [Abstract][Full Text] [Related]